18F-Fludeoxyglucose absorbed dose estimation in fetus during early pregnancy

Nemat Ahmadi, Alireza Karimian, Mehdi Nasri Nasrabadi

DOI: 10.4103/jmss.JMSS_70_20

Abstract


The purpose of this study is to assess a rare case of fetal radiation absorbed dose here through 18F-Fludeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) in early pregnancy (5-week-old fetus). The fetal absorbed dose due to the radiation emitted from the mother's body, the fetus self-dose, and the dose received from CT were computed. The 35-year-old patient, weighing 85 kg, was injected with 370 MBq of 18F-FDG. Imaging started at 1 h with CT acquisition followed by PET imaging. The photon and positron self-dose was calculated by applying the Monte Carlo (MC) GATE (GEANT 4 Application for Tomographic Emission) code. The volume of absorbed dose from the mother's body organs and the absorbed dose from the CT were added to the self-dose to obtain the final dose. The volume of self-dose obtained through MC simulation for the fetus was 3.3 × 10-2 mGy/MBq, of which 2.97 × 10-2 mGy/MBq was associated with positrons and 0.33 × 10-2 mGy/MBq was associated with photons. Biologically, the absorbed dose from CT, 7.3 mGy, had to be added to the total dose. The absorbed dose by the fetus during early pregnancy was higher than the standard value of 2.2 × 10-2 mGy/MBq (MIRD DER) because, during the examinations, the mother's bladder was full. This issue was a concern during updating standards.

Keywords


18F-Fludeoxyglucose, fetus, GATE, maternal dose, Monte Carlo simulation, positron emission tomography/computed tomography, pregnancy

Full Text:

PDF

References


Zanotti-Fregonara P, Champion C, Trébossen R, Maroy R, Devaux JY, Hindié E. Estimation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy. J Nucl Med 2008;49:679-82.

Alibazoglu H, Kim R, Ali A, Green A, La Monica G. FDG uptake in gestational sac. Clin Nucl Med 1997;22:557.

Zanotti-Fregonara P, Jan S, Taieb D, Cammilleri S, Trébossen R, Hindié E, et al. Absorbed 18F-FDG dose to the fetus during early pregnancy. J Nucl Med 2010;51:803-5.

Ahmadi N, Nasrabadi MN, Karimian A, Rahmim A. A TLD based method to estimate bowtie filter shape in PET/CT. Int J Radiat Res 2017;15:383-90.

Brix G, Lechel U, Glatting G, Ziegler SI, Münzing W, Müller SP, et al. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. J Nucl Med 2005;46:608-13.

Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: The second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 2005;46:1023-7.

Takalkar AM, Khandelwal A, Lokitz S, Lilien DL, Stabin MG. 18F-FDG PET in pregnancy and fetal radiation dose estimates. J Nucl Med 2011;52:1035-40.

Zanotti-Fregonara P, Laforest R, Wallis JW. Fetal radiation dose from 18F-FDG in pregnant patients imaged with PET, PET/CT, and PET/MR. J Nucl Med 2015;56:1218-22.

Zanotti-Fregonara P, Chastan M, Edet-Sanson A, Ekmekcioglu O, Erdogan EB, Hapdey S, et al. New fetal dose estimates from 18F-FDG administered during pregnancy: Standardization of dose calculations and estimations with voxel-based anthropomorphic phantoms. J Nucl Med 2016;57:1760-3.

Shi CY, Xu XG, Stabin MG. SAF values for internal photon emitters calculated for the RPI-P pregnant-female models using Monte Carlo methods. Med Phys 2008;35:3215-24.

Visvikis D, Bardies M, Chiavassa S, Danford C, Kirov A, Lamare F, et al. Use of the GATE Monte Carlo package for dosimetry applications. Nucl Instrum Methods Phys Res Sec A 2006;569:335-40.

Zanotti-Fregonara P, Koroscil TM, Mantil J, Satter M. Radiation dose to the fetus from [(18)F]-FDG administration during the second trimester of pregnancy. Health Phys 2012;102:217-9.

Stabin MG, Xu XG, Emmons MA, Segars WP, Shi C, Fernald MJ. RADAR reference adult, pediatric, and pregnant female phantom series for internal and external dosimetry. J Nucl Med 2012;53:1807-13.

Helmrot E, Pettersson H, Sandborg M, Altén JN. Estimation of dose to the unborn child at diagnostic X-ray examinations based on data registered in RIS/PACS. Eur Radiol 2007;17:205-9.

Xie T, Zanotti-Fregonara P, Edet-Sanson A, Zaidi H. Calculations for PET/CT of a patient pregnant with twins. J Nucl Med 2018; 59:1451-58.

Frouin V, Comtat C, Reilhac A, Grégoire MC. Correction of partial-volume effect for PET striatal imaging: Fast implementation and study of robustness. J Nucl Med 2002;43:1715-26.

Viswanathan AN, Yorke ED, Marks LB, Eifel PJ, Shipley WU. Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys 2010;76:S116-22.

Stabin MG. Proposed addendum to previously published fetal dose estimate tables for 18F-FDG. J Nucl Med 2004;45:634-5.

Steenvoorde P, Pauwels EK, Harding LK, Bourguignon M, Marière B, Broerse JJ. Diagnostic nuclear medicine and risk for the fetus. Eur J Nucl Med 1998;25:193-9.

Masuda Y, Kondo C, Matsuo Y, Uetani M, Kusakabe K. Comparison of imaging protocols for 18F-FDG PET/CT in overweight patients: Optimizing scan duration versus administered dose. J Nucl Med 2009;50:844-8.

Ahmadi N, Karimian A, Nasrabadi MN, Rahmim A. Assessment of fetal and maternal radiation absorbed dose in 18F-FDG PET imaging. Int J Radiat Res 2019;17:651-7.


Refbacks

  • There are currently no refbacks.


 

  https://e-rasaneh.ir/Certificate/22728

https://e-rasaneh.ir/

ISSN : 2228-7477